Fund Tracker India by Ishaan Dungarwal
Guide
SHUKRAMEDNSEHealthcarePharmaceuticals & BiotechnologyPharmaceuticals

Mutual fund holdings in Shukra Pharmaceuticals Limited: who holds it and who bought and sold in Oct 2026, with its other institutional holdings, each beside the price.

In Oct 2026, no fund house changed its holding in Shukra Pharmaceuticals.

Shukra Pharmaceuticals Limited

MF holding, % of equity 

Counts every scheme.

0.00%■ 0.00 pp
8,844 shares, ₹0.07 cr
FPI holding, % of equity
0.43%
as of 30 Sep 2026
Fund houses holding
0no change
0 entered, 0 exited · Oct 2026
Promoter pledge
0.00%
as of 30 Sep 2026
Delivery
49.1%■ 0.0 pp
20 Nov 2026
MTF book 

NSE listed no margin trading position for Shukra Pharmaceuticals on any of the 67 days collected, 14 Aug 2026 to 19 Nov 2026.

—
none listed by NSE
Data as of10 sources, each card shows its own date
MF: Oct 2026 portfolios (monthly), 45 fund houses coveredShares outstanding: NSE equity list, 20 Nov 2026Delivery: NSE security-wise delivery, 20 Nov 2026 · 1 days collectedDeals: NSE deal files, 20 Nov 2026SLBM: NSE, 20 Nov 2026 · 68 days collectedMTF: NSE, 19 Nov 2026 · 67 days collectedFlags: NSE, 20 Nov 2026FPI: Shareholding pattern as of 30 Sep 2026, filed 21 Oct 2026Pledge: Shareholding pattern as of 30 Sep 2026Insider: Trades dated 24 Aug 2026 to 21 Nov 2026 (disclosures collected since 3 May 2026)

Shareholding pattern: 0.00 %, Sep 2026.

What it is. Ours adds every fund house's own portfolio file; the shareholding pattern is the company's count of settled shares, on its own share total.

How to read it. Read the filing's figure as the company's own count and the fund-house figure as the sum of the portfolio files below; the two bases differ.

Does not show: depository-receipt shares (ADR, GDR), which are outside the filing's base.

What changed

In Oct 2026, 0 fund houses bought SHUKRAMED and 0 sold, of the 45 houses with portfolios for both Sep 2026 and Oct 2026; index and arbitrage funds left out.

Questions about Shukra Pharmaceuticals

from the figures on this page

Which mutual funds hold Shukra Pharmaceuticals shares?

In Oct 2026, no actively managed fund held Shukra Pharmaceuticals (SHUKRAMED); it was held only by 2 index or passive schemes, together 0.00% of its equity. Largest holdings by shares: Motilal Oswal BSE Healthcare ETF, Bandhan BSE Healthcare Index Fund. Funds holding Shukra Pharmaceuticals, Oct 2026

What is the FII, DII and promoter holding in Shukra Pharmaceuticals?

At the Sep 2026 quarter end (NSE shareholding pattern): promoters 51.15%; FIIs 0.44%; DIIs 0.22%, of which mutual funds 0.00%; individuals up to Rs 2 lakh 7.58%; other public 40.62%.

Mutual funds

What it is. Shares of this company held by mutual funds, taken from the portfolio each fund house publishes for every month end. Some index-only schemes publish only every quarter. "Houses" counts the fund houses holding it in an active scheme.

How to read it. "% of equity" is the shares funds hold divided by all the company's shares. A change between two months compares only the houses with a portfolio in both months. Share counts move when funds add to or cut a holding, or when a split or bonus is applied.

Does not show: Trades inside the month, or why a fund changed its holding.

AMC portfolios, Oct 2026 · 45 fund houses covered

In Oct 2026, compared with Sep 2026: 0 schemes bought, 0 sold, 0 new, 0 exited; net ₹0.00 cr at the Oct 2026 month-end price.

Net MF buying 

Shares bought less shares sold × the month-end price. Active schemes.

₹0.00 cr0 shares
at month-end price ₹74.97
Net buying, % of free float 

Free float = NSE shares outstanding less promoter shares, shareholding pattern of 30 Sep 2026.

0.00%
free float 21.47 cr shares
Schemes holding 

Index funds and ETFs included.

2
Oct 2026, every scheme
How this is counted

Fund houses holding, bought and sold count active schemes only. Index and arbitrage funds are left out. MF holding counts every scheme.

No Oct 2026 portfolio yet from Samco Mutual Fund.

Fund houses

How many fund houses hold it in an active scheme, and how many bought more, cut, entered or left this month. More houses adding than cutting is broad buying, not one fund's bet.

Oct 2026
0no change m/m

holding in an active scheme · 45 houses with both months

AMC portfolios, Oct 2026 · 45 fund houses covered

MF holding vs price

The teal line is the shares all mutual funds held at each month end; the faint line is the month-end price. Teal rising while the faint line falls means funds bought as the price dropped.

12 months
Sep 2026: 0.00% of equity, 8,832 shares, price ₹62.09Oct 2026: 0.00% of equity, 8,844 shares, price ₹74.99

Price implied from fund-house portfolio files (market value ÷ quantity), not an exchange price. % change over 1, 3, 6, 12 months

AMC portfolios, Oct 2026 · 45 fund houses covered

Schemes that changed, Oct 2026

active schemes, share counts vs Sep 2026
New 0
Scheme fund houseSep 2026Oct 2026Change
No active scheme in this bucket for Oct 2026.
Added 0
Scheme fund houseSep 2026Oct 2026Change
No active scheme in this bucket for Oct 2026.
Trimmed 0
Scheme fund houseSep 2026Oct 2026Change
No active scheme in this bucket for Oct 2026.
Exited 0
Scheme fund houseSep 2026Oct 2026Change
No active scheme in this bucket for Oct 2026.

All fund houses and every scheme holding SHUKRAMED → Shares as disclosed, split or bonus adjusted.

Fund houses, Oct 2026

largest change first · active schemes
Fund houseSep 2026Oct 2026Change% of equityActivity
No tracked fund house held it in Sep 2026 or Oct 2026.

with index funds → · "Not compared"

Price

Delayed quote ₹84.20, via Yahoo, last trade 20 Nov 2026, 3:29 PM IST, read after the 3:30 PM IST close. A different source from the NSE close: not on the chart, not in the % above.

History: holders by month, MF holding vs price, month by month

Holders by month

Month endHouses holding (active funds)Fund houses with a portfolioSchemes holding (index funds too)Holders with no portfolio that month
Oct 202604520
Sep 202604620
Aug 202604600
Jul 202604600
Jun 202604400
May 202604600
Apr 202604500
Mar 202604400
Feb 202604400
Jan 202604400
Dec 202504500
Nov 202504400

Fund houses holding it in an active scheme, of those with a portfolio for that month. How to read this table

How this is counted

FPIs named at 1% or more, by shareholding pattern: 30 Sep 2026: 0 (as of each quarter end).

MF holding vs price, % change

12 months · price implied from fund-house portfolio files (market value ÷ quantity)
% change to Oct 2026
OverSinceMF shares heldImplied price
3 monthsJul 2026——
6 monthsApr 2026——
12 monthsOct 2025——
Month by month (table)
MonthMF shares held% of equityImplied priceHouses agreeing
Nov 2025————
Dec 2025————
Jan 2026————
Feb 2026————
Mar 2026————
Apr 2026————
May 2026————
Jun 2026————
Jul 2026————
Aug 2026————
Sep 20268,8320.00%₹62.092 of 2
Oct 20268,8440.00%₹74.992 of 2

Month-end price implied from fund-house portfolio files (market value ÷ quantity), the median across fund houses; not an exchange price. How it is worked out

Oct 2026

Shareholders

Shareholding

What it is. Every listed company reports how its shares are split between promoters and the public, within 21 days of each quarter end (companies on the SME exchanges report every half year). This page groups the public part into foreign investors, Indian institutions and retail.

How to read it. Percentages are of the filing's share base. The change column compares with the previous quarter.

Does not show: Trades between quarters.

as of Sep 2026 · Source: NSE shareholding pattern
Category% of filed sharesChange, pp
Promoter and promoter group51.15%—
Foreign portfolio investors (FPI)0.44%—
Domestic institutions (DII)0.22%—
of which Mutual funds / UTI0.00%—
of which Banks0.11%—
of which Alternative investment funds0.10%—
Resident individuals up to Rs 2 lakh (as the filing defines it)7.58%—
Other public (derived)40.62%—

% of the filing's shares (ADR, GDR left out) at Sep 2026; pp change against the previous quarter end.

How this is counted

Share of the company's shares as filed in its quarterly shareholding pattern (depository-receipt shares are outside the filing's base, so its mutual fund line can sit above the MF holding elsewhere on this page, which is a % of all equity shares). "of which" lines sit inside Domestic institutions. A dash means the filing has no such line, Other public cannot be worked out from the filed lines, or there is no previous quarter to compare.

No line in this filing, so not shown: Insurance companies, Provident and pension funds.

History from Sep 2026: 1 quarter, so no trend yet. Hover a row for every stored quarter.

Named FPIs at 1% or more

Foreign investors who own 1% or more, from the quarterly shareholding pattern. Shows which large foreign funds are on the register.

What it is. Foreign portfolio investors (FPIs) are overseas investors registered with SEBI. The shareholding pattern names every public holder with 1% or more of the company; this card shows the FPIs among them.

How to read it. Filed once a quarter. "Joined" means named this quarter and not last, which can also mean the holder crossed 1% rather than bought a first share. "Left" can likewise mean it fell below 1%.

Does not show: Holdings below 1%, or trades between quarters.

as of 30 Sep 2026
0.43%

FPI category I + II, % of total shares · 0 named at 1% or more

No FPI held 1% or more of Shukra Pharmaceuticals on 30 Sep 2026.

Shareholding pattern as of 30 Sep 2026, filed 21 Oct 2026

Promoter pledge

Share of the promoters' stake pledged as loan collateral. A rising number means more of the owners' shares are borrowed against.

What it is. Promoters sometimes borrow money against their shares by pledging them: the lender holds the shares as security. Promoters report a pledge or its release to the exchange within seven working days, and the quarterly shareholding pattern shows the shares pledged or otherwise encumbered.

How to read it. Shown as a share of the promoter holding and of all the company's shares, once a quarter. Compare quarters to see the direction.

Does not show: The size of the loan, or the lender's terms.

as of 30 Sep 2026
0.00%

of promoter holding · 0.00% of total shares

Promoters had pledged 0 of their 22.49 cr shares on 30 Sep 2026.

Shareholding pattern as of 30 Sep 2026

Delivery

Delivery

Share of the day's traded volume taken into demat instead of squared off the same day. A higher share means more of the trading was buying to hold.

What it is. Of all shares traded in a day, the part that was settled by delivery: the buyer receives the shares in their demat account. NSE counts this per client, so the rest is shares a client bought and sold within the same day (intraday).

How to read it. NSE publishes the share for every stock every day. Stocks differ in how much they are traded within the day, so compare a stock with its own past rather than with another stock. A 5-day figure smooths out single-day noise.

Does not show: Who the buyers were, or whether they plan to keep the shares.

20 Nov 2026
49.1%■ 0.0 pp vs 1-day average

1-day average 49.1% · 1 day collected

NSE security-wise delivery, 20 Nov 2026 · 1 days collected By day, week and month →

F&O and margin

Red flags

The exchange's own lists: F&O ban and surveillance. They say the stock is on a list, not why it moved.

What it is. Exchange lists that restrict trading in a stock: the F&O ban (no fresh F&O positions), and the Additional and Graded Surveillance Measures (ASM and GSM), which tighten trading conditions with steps such as higher margins, narrower price bands and trade-for-trade settlement.

How to read it. The card shows whether the stock is on a list today, from the exchange's daily files.

Does not show: Anything about the company beyond being listed.

20 Nov 2026
No F&O

Shukra Pharmaceuticals has no F&O contracts in NSE's combined open-interest file, so the F&O ban does not apply. NSE listed Shukra Pharmaceuticals under no ASM or GSM stage on 20 Nov 2026. Pledge invocations are not available yet.

NSE, 20 Nov 2026

Nothing to show for Shukra Pharmaceuticals in the period checked Bulk and block deals: No bulk or block deals in Shukra Pharmaceuticals from 23 Aug 2026 to 20 Nov 2026. · Insider and promoter: No insider or promoter trade in Shukra Pharmaceuticals dated 24 Aug 2026 to 21 Nov 2026 was disclosed. · MTF book: NSE listed no margin trading position for Shukra Pharmaceuticals on any of the 67 days collected, 14 Aug 2026 to 19 Nov 2026. · SLBM borrowing: NSE listed no securities-lending (SLB) open position for Shukra Pharmaceuticals on any of the 68 days collected, 14 Aug 2026 to 20 Nov 2026. No SLBM trades in Shukra Pharmaceuticals on 20 Nov 2026.

Sources

AMC monthly portfolios (SEBI disclosure) · Yahoo Finance (delayed quote) · NSE shareholding pattern filings (XBRL), quarterly · NSE security-wise delivery, daily · NSE bulk and block deals, daily · NSE insider trading disclosures (SEBI PIT, XBRL) · NSE F&O ban list, market-wide position limits and surveillance indicators, daily · NSE margin trading disclosure, daily · NSE securities lending and borrowing (SLBS, SLBM), daily. Each card and table shows its own date.

Report a wrong number

Followed pages

Embed this card

Card for this stock: facts with source and date

Copy this into any web page. The image carries its source, date and a link back; it is redrawn each night.